Characteristics and Outcomes of Real-World Patients with Immunotherapy-Refractory Metastatic Melanoma Referred for Evaluation for Tumor Infiltrating Lymphocyte Therapy

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Anay Pachori, Linda Rose Ramsdell, Sarah Nikiforow, Nancy Tang, Charles H. Yoon, Karam Khaddour, Elizabeth Iannotti Buchbinder

DOI: 10.1016/j.jtct.2025.12.960

Cited by: 0

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers CAR-T cell therapy research Immunotherapy and Immune Responses